IFPMA Influenza Vaccine Supply International Task Force
(IFPMA IVS Task Force)
The IFPMA IVS Task Force Influenza vaccine manufactures around the world initiated, in 2000, a collaboration to undertake scientific, technical, regulatory and policy issues raised during interpandemic and pandemic periods. This led, in February 2002, to the establishment of the Influenza Vaccine Supply International Task Force (IVS Task Force), a specialized group within the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).The IFPMA IVS Task Force provides governments and intergovernmental bodies with unique, relevant expertise from research-based vaccine manufactures around the world that are developing vaccines to combat both pandemic and seasonal influenza.To assist public bodies in their preparation against pandemic influenza, the IVS Task Force provides expert opinions on many of the key issues facing planners and policy makers, including vaccination recommendations, information on the level of vaccine usage and vaccine distribution strategies.
Related Pages
15 May 2013,
Scientific and regulatory experts meet in Moscow to explore harmonized approaches for...
18 April 2013,
Vaccine experts recommend practical actions to support vaccine innovation and access around the...
20 May 2013, Geneva, Switzerland
The Annual IFPMA Reception on the occasion of the 66th World Health Assembly

UPDATED! Developing World Health Partnerships Directory
The research-based pharmaceutical industry engages in a wide range of public-private partnerships...

IFPMA Code of Practice
Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...

IFPMA Clinical Trials Portal and Joint Positions on Clinical Trial Results Publication and...
Important online sources of clinical trials information
